Elutia
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Elutia sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Elutia: 10 sponsored US clinical trials, 1 recruiting.
Elutia sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 9 completed. The most-studied condition in this pipeline is Cardiac Arrhythmias, with 1 trials.
Top-decile sponsor footprint
Elutia ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
EluPro Antibiotic-Eluting BioEnvelope Registry
NCT06854081
CanGaroo® Registry Study
NCT04846127
Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation
NCT04645173
Retrospective Experience Of CIED Implantation
NCT04351269
A Retrospective Breast Reconstruction Study
NCT04060134
ViBone in Cervical and Lumbar Spine Fusion
NCT03425682
A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope
NCT02530970
Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)
NCT02073331
CorMatrix ECM for Carotid Repair Following Endarterectomy Registry
NCT01569594
Evaluation Of New Onset Postoperative Atrial Fibrillation
NCT01247974
Therapeutic Areas
What is open in the Elutia pipeline
1 recruiting of 10 indexed (10% open); 9 completed (90%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Cardiac Arrhythmias (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Elutia: open-pipeline peers nationwide
Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Elutia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Abiomed · 10% recruiting · 20 trials
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Alzheimer's Disease Cooperative Study (ADCS) · 10% recruiting · 10 trials
Related
What to do with this Elutia page
10 registered trials is a research-attention snapshot, not an endorsement of Elutia or any single study.
- 1 of Elutia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cardiac Arrhythmias is the condition Elutia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cardiac Arrhythmias trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Elutia pipeline card: 10 registered trials from official public datasets.Report a data error.